753
Views
14
CrossRef citations to date
0
Altmetric
Review Article

Current Treatment Modalities of JIA-associated Uveitis and its Complications: Literature Review

, MD, , MD, , MD, , MD, , BA & , MD, FACS, FACR
Pages 431-439 | Received 09 Mar 2015, Accepted 30 Oct 2015, Published online: 14 Jan 2016

REFERENCES

  • Brewer EJ Jr, Bass J, Baum J, et al. Current proposed revision of JRA criteria. JRA criteria subcommittee of the diagnostic and therapeutic criteria committee of the American rheumatism section of the arthritis foundation. Arthritis Rheum. 1977;20(2 Suppl):195–199.
  • Peterson LS, Mason T, Nelson AM, et al. Juvenile rheumatoid arthritis in Rochester, Minnesota 1960–1993. Is the epidemiology changing? Arthritis Rheum. 1996;39:1385–1390.
  • Feldman DE, De Civita M, Dobkin PL, et al. Effects of adherence to treatment on short-term outcomes in children with juvenile idiopathic arthritis. Arthritis Rheum. 2007;57:905–912.
  • Hoeve M, Kalinina Ayuso V, Schalij-Delfos NE, et al. The clinical course of juvenile idiopathic arthritis-associated uveitis in childhood and puberty. Br J Ophthalmol. 2012;96:852–856.
  • Foster CS. Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol. 2003;14:395–398.
  • Saurenmann RK, Levin AV, Feldman BM, et al. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term follow up study. Arthritis Rheum. 2007;56:647–657.
  • Stanley LC, Ward-Smith P. The diagnosis and management of juvenile idiopathic arthritis. J Pediatr Health Care. 2011;25:191–194.
  • Päivönsalo-Hietanen T, Tuominen J, et al. Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand. 2000;78:84–88.
  • Oren B, Sehgal A, Simon JW, et al. The prevalence of uveitis in juvenile rheumatoid arthritis. J AAPOS. 2001;5:2–4.
  • Akduman L, Kaplan HJ, Tychsen L. Prevalence of uveitis in an outpatient juvenile arthritis clinic: onset of uveitis more than a decade after onset of arthritis. J Pediatr Ophthalmol Strabismus. 1997;34:101–106.
  • Boone MI, Moore TL, Cruz OA. Screening for uveitis in juvenile rheumatoid arthritis. J Pediatr Ophthalmol Strabismus. 1998;35:41–43.
  • Carvounis PE, Herman DC, Cha SS, et al. Ocular manifestations of juvenile rheumatoid arthritis in Olmsted County, Minnesota: a population-based study. Graefes Arch Clin Exp Ophthalmol. 2005;243:217–221.
  • Heiligenhaus A, Foeldvari I, Edelsten C, et al.; Multinational Interdisciplinary Working Group for Uveitis in Childhood. Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood. Arthritis Care Res. 2012;64:1365–1372.
  • Ozdal PC, Vianna RN, Deschênes J. Visual outcome of juvenile rheumatoid arthritis-associated uveitis in adults. Ocul Immunol Inflamm. 2005;13:33–38.
  • Kotaniemi K, Arkela-Kautiainen M, Haapasaari J, et al. Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients. Ann Rheum Dis. 2005;64:871–874.
  • Gregory AC, Kempen JH, Daniel E, et al. Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the SITE study. Ophthalmology. 2013;120:186–192.
  • Adán A, Gris O, Pelegrin L, et al. Explantation of intraocular lenses in children with juvenile idiopathic arthritis-associated uveitis. J Cataract Refract Surg. 2009;35:603–605.
  • Foster CS, Havrlikova K, Baltatzis S, et al. Secondary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Acta Ophthalmol Scand. 2000;78:576–579.
  • Chia A, Lee V, Graham EM, et al. Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program. Am J Ophthalmol. 2003;135:757–762.
  • Malleson P. Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rheumatol. 1998;25:1242.
  • Angeles-Han ST, Pelajo CF, Vogler LB, et al. Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry. J Rheumatol. 2013;40:2088–2096.
  • Kalinina Ayuso V, Ten Cate HA, van der Does P, et al. Male gender as a risk factor for complications in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2010;149:994–999.
  • Kotaniemi K, Arkela-Kautiainen M, Haapasaari J, et al. Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients. Ann Rheum Dis. 2005;64:871–874.
  • Cassidy J, Kivlin J, Lindsley C, et al. Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics. 2006; 117:1843–1845.
  • Wentworth BA, Freitas-Neto CA, Foster CS. Management of pediatric uveitis. F1000Prime Rep. 2014;6:41.
  • Vitale A, Kump LI, Foster CS. Uveitis affecting infants and children. In: Harnett ME, ed. Pediatric Retina. 2nd edn. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2013.
  • Fiorelli VM, Bhat P, Foster CS. Nonsteroidal anti-inflammatory therapy and recurrent acute anterior uveitis. Ocul Immunol Inflamm. 2010;18:116–120.
  • Keenan GF, Giannini EH, Athreya BH. Clinically significant gastropathy associated with nonsteroidal antiinflammatory drug use in children with juvenile rheumatoid arthritis. J Rheumatol. 1995;22:1149–1151.
  • De Silva B, Banney L, Uttley W, et al. Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis. Pediatr Dermatol. 2000;17:480–483.
  • Vora SS, Bengtson CE, Syverson GD, et al. An evaluation of the utility of routine laboratory monitoring of juvenile idiopathic arthritis (JIA) patients using non-steroidal anti-inflammatory drugs (NSAIDs): a retrospective review. Pediatr Rheumatol Online J. 2010;8:11.
  • Heiligenhaus A, Mingels A, Heinz C, et al. Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication. Eur J Ophthalmol. 2007;17:743–748.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT, et al; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516.
  • Simonini G, Paudyal P, Jones GT, et al. Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. Rheumatology. 2013;52:825–831.
  • Pilly B, Heath G, Tschuor P, et al. Overview and recent developments in the medical management of paediatric uveitis. Expert Opin Pharmacother. 2013; 14:1787–1795.
  • Levy-Clarke G, Jabs DA, Read RW, et al. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2014;121:785–796.
  • Bravo-Ljubetic L, Peralta-Calvo J, Noval S, et al. Adalimumab therapy for refractory childhood uveitis. J AAPOS. 2013;17:456–459.
  • Zannin ME, Birolo C, Gerloni VM, et al. Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis:1-year followup data from the Italian Registry. J Rheumatol. 2013;40:74–79.
  • Simonini G, Taddio A, Cattalini M, et al. Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab. Arthritis Care Res. 2011;63:612–618.
  • Jan O. Aasly. Bilateral optic neuritis associated with the use of infliximab. Case Rep Ophthalmol Med. 2011;2011:232986.
  • Suhler EB, Smith JR, Wertheim MS, et al. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. Arch Ophthalmol. 2005;123:903–912.
  • Saurenmann RK, Levin AV, Rose JB, et al. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology. 2006;45:982–989.
  • Mansour AM. Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol. 2007;91:274–276.
  • Kok VC, Horng JT, Huang JL, et al. Population-based cohort study on the risk of malignancy in East Asian children with juvenile idiopathic arthritis. BMC Cancer. 2014;14:634.
  • Ruperto N, Martini A. Juvenile idiopathic arthritis and malignancy. Rheumatology. 2014;53:968–974.
  • Kump LI, Castañeda RA, Androudi SN, et al. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. Ophthalmology. 2006; 113:1874–1877.
  • Yu EN, Meniconi ME, Tufail F, et al. Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis. Ocul Immunol Inflamm. 2005;13:353–360.
  • Thorne JE, Woreta F, Kedhar SR, et al. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007;143:840–846.
  • Woreta F, Thorne JE, Jabs DA, et al. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2007;143:647–655.
  • de Boer J, Wulffraat N, Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol. 2003;87:879–884.
  • Heiligenhaus A, Niewerth M, Ganser G, et al.; German Uveitis in Childhood Study Group. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology. 2007;46:1015–1019.
  • Lam DS, Law RW, Wong AK. Phacoemulsification, primary posterior capsulorhexis, and capsular intraocular lens implantation for uveitic cataract. J Cataract Refract Surg. 1998;24:1111–1118.
  • Kanski JJ. Uveitis in juvenile chronic arthritis. Clin Exp Rheumatol. 1990;8:499–503.
  • Thorne JE, Woreta F, Kedhar SR, et al. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007;143:840–846.
  • Thorne JE, Woreta FA, Dunn JP, et al. Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology. 2010;117:1436–1441.
  • Lam LA, Lowder CY, Baerveldt G, et al. Surgical management of cataracts in children with juvenile rheumatoid arthritis-associated uveitis. Am J Ophthalmol. 2003;135:772–778.
  • Lundvall A, Zetterström C. Cataract extraction and intraocular lens implantation in children with uveitis. Br J Ophthalmol. 2000;84:791–793.
  • Murthy SI, Pappuru RR, Latha KM, et al. Surgical management in patient with uveitis. Indian J Ophthalmol. 2013;61:284–290.
  • Lundvall A, Zetterström C. Cataract extraction and intraocular lens implantation in children with uveitis. Br J Ophthalmol. 2000;84:791–793.
  • Murthy SI, Pappuru RR, Latha KM, et al. Surgical management in patient with uveitis. Indian J Ophthalmol. 2013;61:284–290.
  • BenEzra D, Cohen E. Cataract surgery in children with chronic uveitis. Ophthalmology. 2000;107:1255–1260.
  • Lam LA, Lowder CY, Baerveldt G, et al. Surgical management of cataracts in children with juvenile rheumatoid arthritis-associated uveitis. Am J Ophthalmol. 2003;135:772–778.
  • Sijssens KM, Los LI, Rothova A, et al. Long-term ocular complications in aphakic versus pseudophakic eyes of children with juvenile idiopathic arthritis-associated uveitis. Br J Ophthalmol. 2010;94:1145–1149.
  • Foster CS, Barrett F. Cataract development and cataract surgery in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Ophthalmology. 1993;100:809–817.
  • Flynn HW Jr, Davis JL, Culbertson WW. Pars plana lensectomy and vitrectomy for complicated cataracts in juvenile rheumatoid arthritis. Ophthalmology. 1988;95:1114–1119.
  • Jensen AA, Basti S, Greenwald MJ, et al. When may the posterior capsule be preserved in pediatric intraocular lens surgery? Ophthalmology. 2002;109:324–327; discussion 328.
  • Kanski JJ, Shun-Shin GA. Systemic uveitis syndromes in childhood: an analysis of 340 cases. Ophthalmology. 1984;91:1247–1252.
  • Sijssens KM, Rothova A, Berendschot TT, et al. Ocular hypertension and secondary glaucoma in children with uveitis. Ophthalmology. 2006;113:853–859.
  • Foster CS, Davanzo R, Flynn TE, et al. Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis. J Ocul Pharmacol Ther. 2010;26:475–483.
  • Yu EN, Meniconi ME, Tufail F, et al. Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis. Ocul Immunol Inflamm. 2005;13:353–360.
  • Smith SL, Pruitt CA, Sine CS, et al. Latanoprost 0.005% and anterior segment uveitis. Acta Ophthalmol Scand. 1999;77:668–672.
  • Markomichelakis NN, Kostakou A, Halkiadakis I, et al. Efficacy and safety of latanoprost in eyes with uveitic glaucoma. Graefes Arch Clin Exp Ophthalmol. 2009;247:775–780.
  • Freedman SF, Rodriguez-Rosa RE, Rojas MC, et al. Goniotomy for glaucoma secondary to chronic childhood uveitis. Am J Ophthalmol. 2002;133:617–621.
  • Ho CL, Wong EY, Walton DS. Goniosurgery for glaucoma complicating chronic childhood uveitis. Arch Ophthalmol. 2004;122:838–844.
  • Bohnsack BL, Freedman SF. Surgical outcomes in childhood uveitic glaucoma. Am J Ophthalmol. 2013;155:134–142.
  • Kafkala C, Hynes A, Choi J, et al. Ahmed valve implantation for uncontrolled pediatric uveitic glaucoma. J AAPOS. 2005;9:336–340.
  • Wiese K, Heiligenhaus A, Heinz C. Trabeculectomy in uveitis associated with juvenile idiopathic arthritis: long-term results in pediatric secondary glaucoma. Ophthalmologe. 2014;111:330–338.
  • Lipton NL, Crawford JS, Greenberg ML, et al. The risk of iridocyclitis in juvenile rheumatoid arthritis. Can J Ophthalmol. 1976;11:26–30.
  • Chylack LT Jr. The ocular manifestations of juvenile rheumatoid arthritis. Arthritis Rheum. 1977;20(2 Suppl):217–223.
  • Yu EN, Paredes I, Foster CS. Surgery for hypotony in patients with juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm. 2007;15:11–17.
  • Nicholson BP, Zhou M, Rostamizadeh M. Epidemiology of epiretinal membrane in a large cohort of patients with uveitis. Ophthalmology. 2014;121:2393–2398.
  • Tanawade RG, Tsierkezou L, Bindra MS. Visual outcomes of pars plana vitrectomy with epiretinal membrane peel in patients with uveitis. Retina. 2015;35:736–741.
  • Habib MS, Steel DH, Ling R, et al. Vitrectomy with membrane peeling for vasocentric idiopathic epiretinal membranes. Retina. 2008;28:981–986.
  • Ducos de Lahitte G, Terrada C, et al. Maculopathy in uveitis of juvenile idiopathic arthritis: an optical coherence tomography study. Br J Ophthalmol. 2008;92:64–69.
  • Ouyang Y, Keane PA, Sadda SR, et al. Detection of cystoid macular edema with three-dimensional optical coherence tomography versus fluorescein angiography. Invest Ophthalmol Vis Sci. 2010;51:5213–5218.
  • Davis J. Current concepts in the management of uveitic macular edema. Adv Stud Ophthalmol. 2010;7:60–66.
  • Ossewaarde-van Norel A, Rothova. A clinical review: update on treatment of inflammatory macular edema. Ocul Immunol Inflamm. 2011;19:75–83.
  • Slabaugh MA, Herlihy E, Ongchin S, et al. Efficacy and potential complications of difluprednate use for pediatric uveitis. Am J Ophthalmol. 2012;153:932–938.
  • Hariprasad SM, Akduman L, Clever JA, et al. Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%. Clin Ophthalmol. 2009;3:147–154.
  • Flach AJ. Topical nonsteroidal antiinflammatory drugs in ophthalmology. Int Ophthalmol Clin. 2002;42:1–11.
  • Roberts CW, Brennan KM. A comparison of topical diclofenac with prednisolone for post cataract inflammation. Arch Ophthalmol. 1995;113:725–727.
  • Leder HA, Jabs DA, Galor A, et al. Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis. Am J Ophthalmol. 2011;152:441–448.
  • Sen HN, Vitale S, Gangaputra SS, et al. Periocular corticosteroid injections in uveitis: effects and complications. Ophthalmology. 2014;121:2275–2286.
  • Habot-Wilner Z, Sallam A, Roufas A, et al. Periocular corticosteroid injection in the management of uveitis in children. Acta Ophthalmol. 2010;88:e299–e304.
  • Sallam A, Comer RM, Chang JH, et al. Short-term safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema in children. Arch Ophthalmol. 2008;126:200–205.
  • Totan Y, Güler E, Guragaç FB, et al. Cystoid macular edema associated with juvenile idiopathic arthritis resolved by a dexamethasone intravitreal implant. J Pediatr Ophthalmol Strabismus. 2014;51:e25–e28.
  • Bourgault S, Aroichane M, Wittenberg LA, et al. Treatment of refractory uveitic macular edema with dexamethasone intravitreal implants in a pediatric patient with bilateral granulomatous idiopathic panuveitis: a case report. J Ophthalmic Inflamm Infect. 2013;3:61.
  • Taylor SRJ, Tomkins-Netzer O, et al. Dexamethasone implant in pediatric uveitis. Ophthalmology. 2012;119:2412–2412.
  • Weiss K, Steinbrugger I, Weger M, et al. Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab. Eye. 2009; 23:1812–1818.
  • Mackensen F, Heinz C, Becker MD, et al. Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study. Retina. 2008;28:41–45.
  • Acharya NR, Hong KC, Lee SM. Ranibizumab for refractory uveitis-related macular edema. Am J Ophthalmol. 2009;148:303–309.
  • Rathi VM, Vyas SP, Vaddavalli PK, et al. Phototherapeutic keratectomy in pediatric patients in India. Cornea. 2010;29:1109–1112.
  • Autrata R, Rehurek J, Vodicková K. Phototherapeutic keratectomy in children:5-year results. J Cataract Refract Surg. 2004; 30:1909–1916.
  • Sharma N, Mannan R, Sinha R, et al. Excimer laser phototherapeutic keratectomy for the treatment of silicone oil-induced band-shaped keratopathy. Eye Contact Lens. 2011;37:282–285.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.